MedTrace Logo

Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection

NCT07482618 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-03-20

No results posted yet for this study

Summary

Tolperison is an antispastic agent used in the treatment of spasticity. Studies on tolperison are limited, and the literature on its effectiveness against spasticity and neuropathic pain is also limited.

Conditions

  • Spastic Hemiplegia

Sponsors & Collaborators

  • Ayse Guc

    lead OTHER_GOV

  • Kayseri City Hospital

    collaborator OTHER_GOV

Principal Investigators

  • Melike Yavuz · Kayseri City Hospital Physical Medicine and Rehabilitation

Eligibility

Min Age
18 Months
Max Age
80 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-13
Primary Completion
2026-05-25
Completion
2026-07-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07482618 on ClinicalTrials.gov